Michael Barbella, Managing Editor07.07.22
Stimwave Technologies (Stimwave) and Aspen Medical Products (Aspen) are working together to develop a wearable pain management accessory for chronic pain treatment.
“We are constantly looking for ways to improve our therapies' patient and physician experience. The ability for a chronic pain patient to actively participate in their care, alongside their doctor is a critical component in improving their quality of life,” Stimwave CEO Aure Bruneau said. “Our HF-EMC power transfer technology gives us a unique opportunity to combine our system with Aspen’s design experience that millions of patients and clinicians have trusted for decades. Together, we can now provide an improved patient-specific solution. We are also committed to developing additional therapy options that combine bracing and neuromodulation to deliver the next generation of chronic pain management.”
Stimwave’s Freedom SCS platform is designed to treat chronic pain typically associated with a patient’s back and legs by stimulating nerves along their spine. Unlike other neurostimulator devices on the market, Stimwave’s Freedom SCS therapy is powered wirelessly. To enhance the platform, Stimwave and Aspen will develop a wearable that comfortably and securely houses the systems’ external components. The new wearable can be worn under clothing, allowing for simplified, discreet, and uninterrupted treatment.
“This partnership allows us to leverage Stimwave and Aspen’s combined capabilities into one elegant and concise system that helps patients suffering from chronic pain get back to their normal lives faster,” Aspen CEO Jim Cloar said. “Central to everything we do is the necessity to be a significant part of the puzzle of treating pain and changing lives for the better. We are continually focused on delivering the highest-quality products and solutions that enable pain relief and promote mobility.”
Stimwave Technologies Inc. is a privately held medical device company that develops, manufactures, and commercializes wirelessly powered, injectable, microtechnology neurostimulators. These devices provide patients with a safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of pain management.
Founded in 1994, Aspen Medical Products LLC develops and manufactures spinal orthopedics and pain therapy solutions. Designed to restore function and alleviate pain, Aspen’s products address various patient needs across the continuum of care to help them resume activities of daily living. The company is headquartered in Irvine, Calif.
“We are constantly looking for ways to improve our therapies' patient and physician experience. The ability for a chronic pain patient to actively participate in their care, alongside their doctor is a critical component in improving their quality of life,” Stimwave CEO Aure Bruneau said. “Our HF-EMC power transfer technology gives us a unique opportunity to combine our system with Aspen’s design experience that millions of patients and clinicians have trusted for decades. Together, we can now provide an improved patient-specific solution. We are also committed to developing additional therapy options that combine bracing and neuromodulation to deliver the next generation of chronic pain management.”
Stimwave’s Freedom SCS platform is designed to treat chronic pain typically associated with a patient’s back and legs by stimulating nerves along their spine. Unlike other neurostimulator devices on the market, Stimwave’s Freedom SCS therapy is powered wirelessly. To enhance the platform, Stimwave and Aspen will develop a wearable that comfortably and securely houses the systems’ external components. The new wearable can be worn under clothing, allowing for simplified, discreet, and uninterrupted treatment.
“This partnership allows us to leverage Stimwave and Aspen’s combined capabilities into one elegant and concise system that helps patients suffering from chronic pain get back to their normal lives faster,” Aspen CEO Jim Cloar said. “Central to everything we do is the necessity to be a significant part of the puzzle of treating pain and changing lives for the better. We are continually focused on delivering the highest-quality products and solutions that enable pain relief and promote mobility.”
Stimwave Technologies Inc. is a privately held medical device company that develops, manufactures, and commercializes wirelessly powered, injectable, microtechnology neurostimulators. These devices provide patients with a safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of pain management.
Founded in 1994, Aspen Medical Products LLC develops and manufactures spinal orthopedics and pain therapy solutions. Designed to restore function and alleviate pain, Aspen’s products address various patient needs across the continuum of care to help them resume activities of daily living. The company is headquartered in Irvine, Calif.